ABCL — AbCellera Biologics Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1703057 ·
Last close
$12.70
Market Cap
$4.12B
52W High
$13.18
52W Low
$2.74
ADV30
5,401,040
Next earnings
2026-11-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 4,050,000 | — | -58,923,000 | -55,427,000 | 1,307,575,000 | 120,065,000 | 411,555,000 |
| Mar 2026 | 8,315,000 | — | -53,180,000 | -43,165,000 | 1,307,112,000 | 77,063,000 | 369,029,000 |
| Dec 2025 | 44,853,000 | — | -25,266,000 | -8,945,000 | 1,356,950,000 | 128,513,000 | 390,046,000 |
| Sep 2025 | 8,955,000 | — | -73,549,000 | -57,119,000 | 1,355,992,000 | 83,159,000 | 391,954,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-94,937,000
Investing CF
$97,886,000
Financing CF
$25,072,000
CapEx
$-24,734,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.63
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-128,074,000
Inventory
$7,578,000
Receivables
$95,425,000
ST Investments
$420,039,000
EBIT TTM
$-210,918,000
Pretax Income TTM
$-196,769,000
Interest Exp TTM
$42,000
Analysts
8
Yahoo Snapshot (yfinance, live)
Total Revenue
$66,170,000
EBITDA
$-199,960,000
Free Cash Flow
$-46,431,124
Enterprise Value
$2,934,511,872
Total Cash
$540,104,000
Total Debt
$135,616,992
Shares Out
324,047,363
Trailing EPS
$-0.54
Book Value
$2.92
ROE
-17.3%
ROA
-10.4%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 75,128,000 | -203,213,000 | -146,412,000 | 1,356,950,000 | 390,046,000 | 966,904,000 | -131,295,000 |
| Dec 2024 | 28,833,000 | -301,146,000 | -162,857,000 | 1,360,553,000 | 304,469,000 | 1,056,084,000 | -108,556,000 |
| Dec 2023 | 38,025,000 | -223,052,000 | -146,398,000 | 1,488,094,000 | 335,776,000 | 1,152,318,000 | -43,877,000 |
| Dec 2022 | 485,424,000 | 227,065,000 | 158,519,000 | 1,540,907,000 | 307,630,000 | 1,233,277,000 | 277,360,000 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
$112,125,000
NetIncome TTM
$-70,104,000
OpCashFlow TTM
$0
Assets (Latest)
$1,356,950,000
Forward EPS
$-0.71
Max Pain — expiry 2026-10-16
max pain strike: $11.00 · spot: $13.15 · call oi: 18,393 · put oi: 8,897
Expected Move to 2026-10-16:
±$1.95
(14.83%) —
implied range
$11.20 –
$15.10
· ATM straddle on $13.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| VKTX | Viking Therapeutics, Inc. | $4.15B | $35.56 | — |
| TNGX | Tango Therapeutics, Inc. | $4.20B | $24.92 | — |
| INDV | Indivior Pharmaceuticals, Inc. | $4.23B | $35.82 | — |
| EWTX | Edgewise Therapeutics, Inc. | $4.27B | $39.34 | — |
| TLX | Telix Pharmaceuticals Ltd | $3.89B | $11.45 | — |
News headlines (Yahoo Finance, 1h cache)
AbCellera Announces Presentation of Phase 2 Data for ABCL635 at the IMS World Congress on Menopause 2026
2026-09-16 20:05 · Yahoo
Can AbCellera Biologics (ABCL)’s Vertex Pharmaceuticals Incorporated (VRTX) Deal Turn its TCE Platform Into a Breakthrough?
2026-08-14 22:53 · Yahoo
AbCellera (ABCL) Q2 2026 Earnings Call Transcript
2026-08-13 00:31 · Yahoo
AbCellera Biologics (ABCL) Is Up 60.3% After Strong Phase 2 Menopause Data For ABCL635 - Has The Bull Case Changed?
2026-08-12 07:10 · Yahoo
AbCellera Biologics (ABCL) Stock Sees Fair Value Lift After Clinical Data And Jazz Deal
2026-08-12 06:14 · Yahoo
AbCellera Biologics (ABCL) Could Be 33% Overvalued Following ABCL635 Phase 2 Results
2026-08-11 21:11 · Yahoo
Why Did ABCL, REPL, ABNB Stocks Hit 52-Week Highs Today?
2026-08-11 02:31 · Yahoo
AbCellera (ABCL) Rockets 44% as Hot Flash Treatment Brightens Growth Outlook
2026-08-10 21:40 · Yahoo
AbCellera Announces Pricing of Oversubscribed $200 Million Public Offering of Common Shares and Pre-Funded Warrants
2026-08-13 04:05 · Yahoo
AbCellera Stock Jumps 33% on a Positive Menopause Trial
2026-08-10 16:05 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.